Status:
COMPLETED
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality
Lead Sponsor:
Beauty Health
Collaborating Sponsors:
Skin Surgery Medical Group
ATS Clinical Research
Conditions:
Androgenic Alopecia
Eligibility:
All Genders
30-55 years
Phase:
NA
Brief Summary
The study aims to assess the efficacy and safety of Keravive by Hydrafacial treatments and Keravive Peptide Spray for scalp health and enhancing hair quality in patients with androgenic alopecia. This...
Detailed Description
This study is intended to be a single arm study. Suitable subjects who meet all inclusion criteria and consented will undergo 3 in-office Keravive by Hydrafacial treatments at baseline and Weeks 4 and...
Eligibility Criteria
Inclusion
- Norwood Scale score of 2, 3 or 3 Vertex (males) and Ludwig Classification of Type I-1, I-2 or I-3 (females).
Exclusion
- Non-study hair loss treatments (e.g., dutasteride, finasteride, minoxidil, nutraceuticals, PRP therapy, laser or LED scalp treatments, etc.)
- Salon treatments such as straightening, perms or coloring.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06112782
Start Date
July 1 2019
End Date
January 31 2020
Last Update
November 1 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Rebecca Fitzgerald MD Inc
Los Angeles, California, United States, 90004
2
Laser & Skin Surgery Medical Group, Inc
Sacramento, California, United States, 95816
3
ATS Clinical Research
Santa Monica, California, United States, 90404
4
Callender Center for Clinical Research
Glenn Dale, Maryland, United States, 20769